Mesoblast (MESO) Earnings Date & Reports

Mesoblast Ltd is a commercial-stage biotechnology company engaged in developing and commercializing allogeneic (off-the-shelf) cellular medicines for severe inflammatory conditions... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

MESO is expected to report earnings to fall 161.54% to 7 cents per share on November 25

Q3'26

Est.

$0.08

Q2'26

Missed

by $0.13

Q1'26

Est.

$-0.03

Q4'25

Beat

by $0.04

Q3'25

Beat

by $0.03

The last earnings report on August 26 showed earnings per share of -12 cents, missing the estimate of 0 cents. With 91.50K shares outstanding, the current market capitalization sits at 1.97B.

View a ticker or compare two or three

MESO

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for MESO